BioCanCell Announces Terms of $25 Million Funding Round
Jan 23, 2018 13:02 pm UTC| Business
JERUSALEM, Jan. 23, 2018 -- BioCanCell Ltd. (TASE:BICL) (the “Company"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer,...
Cuba Ventures Corp. welcomes Bhavnani Corporation and CEO Dileep Bhavnani to the advisory board
Jan 23, 2018 13:02 pm UTC| Business
VANCOUVER, British Columbia, Jan. 23, 2018 -- Cuba Ventures Corp. (TSX-V:CUV) (Frankfurt:IJA2) (OTCBB:MPSFF) (the “Company”) - is pleased to announce that further to the September 19th, 2017 signed letter of intent...
MaX by Metaswitch Brings Breakthrough Group Collaboration Services to Mobile Networks
Jan 23, 2018 13:02 pm UTC| Business
LOS ALTOS, Calif., Jan. 23, 2018 -- Cloud native communications software leader Metaswitch today announced MaX by Metaswitch™, a revolutionary communications and collaboration product family that enables mobile network...
Unravel Data Secures $15 million in Series B Funding to Accelerate Innovation in APM for Big Data
Jan 23, 2018 13:01 pm UTC| Business
MENLO PARK, Calif., Jan. 23, 2018 -- Unravel Data, the industry's only Application Performance Management (APM) platform designed for Big Data, today announced that it has secured $15 million in Series B financing led...
Endexx Reports Strong Full-Year 2017 Results
Jan 23, 2018 13:01 pm UTC| Business
Company Sees Revenues Up 127% Year Over Year Holistic Earth Remedies LLC, Acquisition Has Generated $85-90K Annually in the Past Two Years and Will Add to Fiscal 2018 Revenues CAVE CREEK, AZ , Jan. 23, 2018 ...
Novo Receives Comet Well Programme of Works Approval
Jan 23, 2018 13:01 pm UTC| Business
VANCOUVER, British Columbia, Jan. 23, 2018 -- Novo Resources Corp. (“Novo” or the “Company”) (TSX-V:NVO) (OTCQX:NSRPF) is pleased to announce that the Programme of Works (“POW”) submission for exploration activities at...
Akari Therapeutics Strengthens Board with Two Senior Industry Appointments
Jan 23, 2018 13:01 pm UTC| Business
NEW YORK and LONDON, Jan. 23, 2018 -- Akari Therapeutics, Plc (NASDAQ:AKTX) (“Akari” or “the Company”), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat...